expenses (4.51) (59.97) (5.21) (2,480.95) Financial cost (0.03) (0.40) (0.06) (28.57) Share of loss in associates (15.06) (200.27) (11.71) (5,576.19) Total expenses (32.57) (433.11) (33.99) (16,185.71
impairment of investments in associate (0.01) (0.05) (1.64) (268.85) Management benefit expenses (11.30) (58.89) (14.16) (2,321.31) Financial cost (0.12) (0.63) (0.14) (22.95) Share of loss in associates
new ordinary shares with a par value of Baht 100.00 per share, at a price of Baht 649.88 per share, totaling Baht 150.00 million. It will be implemented simultaneously with the acquisition of HECH's
Expenses 31.25 35.24 (3.99) (11.13) Net Profit (Loss) (59.03) 58.74 (117.77) (200.49) Earnings per share (Baht per share) (0.05) 0.05 (0.10) (200.00) Net Profit The company and subsidiaries realized net loss
Administration Expenses 31.25 35.23 (3.98) (11.30) Net Profit (Loss) (59.03) 58.74 (117.77) (200.49) Earnings per share (Baht per share) (0.05) 0.05 (0.10) (200.00) Net Profit The company and subsidiaries realized
28.3% compared to 31.6% which has an earnings per share of Bt1.52. However, excluding the special items for 2016, net profit attributable to equity holders of the Company will decrease by Bt 65.4 million
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
which decreasing by Bt66.2 million or -27.3%(y-o-y) and of Bt40.9 million or -7.2%(y-o-y), representing Net profit margin of 19.2% and 27.8% respectively. Thus have earnings per share of Bt0.28 and Bt0.82
34.2% and 32.6% respectively. The earnings per share of Q3/2018 and the nine months of 2018 were Bt0.48 and Bt1.36. Table summarized the operating results of the Group (unit : Bt million) Page 3 of 7 1.1
business relating to the main business of the Company and make the payment for assets acquisition with share of WCIH not exceeding of 101,849,993 shares or 56% of total WCIH shares resulting in termination